Surgical Outcomes of Lenvatinib Treatment Followed by Liver Resection for Advanced Hepatocellular Carcinoma Larger than 10 cm
Preoperative lenvatinib treatment followed by hepatectomy for large HCC (> 10 cm) may reduce recurrence, particularly distant metastases, and potentially improve long-term survival. This approach may be a promising strategy for large HCCs, which traditionally have a poor prognosis with upfront surgery alone.
Authors
- Katsuro Enomoto
- Yuki Adachi (ORCID: https://orcid.org/0000-0002-7917-2360)
- T Takizawa
- Koji Imai (ORCID: https://orcid.org/0000-0001-9318-1450)
- Hideki Yokoo (ORCID: https://orcid.org/0000-0002-6203-8528)
- Hiroyuki Takahashi (ORCID: https://orcid.org/0000-0001-7003-5151)
- Shoichiro Mizukami (ORCID: https://orcid.org/0009-0001-9182-8369)
- Hiroki Takahata
- Kai Makino
Institutions
- Asahikawa Medical University (JP)
Publication Details
- Journal
- Cancers
- Published
- 2025-08-28
- DOI
- https://doi.org/10.3390/cancers17172818
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00